Canagliflozin: Cardiovascular and Renal outcomes

This session will review Canagliflozin and the cardiovascular and renal outcomes from the CANVAS programme, and discuss the clinical relevance of these findings. How should these results impact our prescribing?

Wednesday 14th November 2018

12:00 - 12:15

Product Platform - Workshop

Napp Diabetes Logo


Dr Janaka Karalliedde
Consultant in Diabetes

Our site is intended for UK Healthcare Professionals

Are you a UK Healthcare Professional?

We’re sending you to our partner charity’s site. 

DRWF provide information and support for people with diabetes and their friends & families